Showing 9,081 - 9,100 results of 29,259 for search '(( 5 ((ng decrease) OR (nn decrease)) ) OR ( 50 ((mean decrease) OR (a decrease)) ))', query time: 1.10s Refine Results
  1. 9081
  2. 9082

    Image_5_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.tif by Ni An (511459)

    Published 2024
    “…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”
  3. 9083

    Data_Sheet_1_Characterization of a Novel Functional Trimeric Catechol 1,2-Dioxygenase From a Pseudomonas stutzeri Isolated From the Gulf of Mexico.docx by Julieta Rodríguez-Salazar (8931386)

    Published 2020
    “…The purified PsC12DO enzyme was found as an active trimer, with a molecular mass of 107 kDa. Increasing NaCl concentration in the enzyme reaction gradually reduced activity; in high salt concentrations (0.7 M NaCl) quaternary structural analysis determined that the enzyme changes to a dimeric arrangement and causes a 51% decrease in specific activity on catechol substrate. …”
  4. 9084

    Image_2_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.tiff by Ni An (511459)

    Published 2024
    “…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”
  5. 9085

    Image_4_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.tif by Ni An (511459)

    Published 2024
    “…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”
  6. 9086

    Image_1_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.tif by Ni An (511459)

    Published 2024
    “…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”
  7. 9087

    Image_3_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.tif by Ni An (511459)

    Published 2024
    “…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”
  8. 9088

    Table_1_T2DM may exert a protective effect against digestive system tumors in East Asian populations: a Mendelian randomization analysis.xlsx by Ni An (511459)

    Published 2024
    “…</p>Results<p>T2DM is associated with a reduced risk of esophageal (OR: 0.77, 95% CI: 0.71 to 0.83, P< 0.001), gastric (OR: 0.87, 95% CI: 0.84 to 0.90, P< 0.001) and colorectal cancer (OR: 0.88, 95% CI: 0.85 to 0.91, P< 0.001) and hepatocellular carcinoma (OR: 0.92, 95% CI: 0.86 to 0.97, P = 0.005) and an increased risk of pancreatic cancer (OR: 1.92, 95% CI: 1.47 to 2.50, P< 0.001) in East Asian population. …”
  9. 9089

    Data_Sheet_1_Effectiveness of a program to lower unwanted media screens among 2–5-year-old children: a randomized controlled trial.docx by Nimran Kaur (11008865)

    Published 2024
    “…In the post-intervention assessment, 161 and 166 families continued while, at the follow-up assessment, 154 and 147 were in the intervention and control arm, respectively. The mean difference in ST on a typical day [27.7 min, 95% Confidence Interval (CI) 5.1, 50.3] at the post-intervention assessment significantly (p < 0.05) decreased in the intervention (102.6 ± 98.5 min) arm as compared with the control (130.3 ± 112.8 min) arm. …”
  10. 9090

    Data_Sheet_1_Effectiveness of a program to lower unwanted media screens among 2–5-year-old children: a randomized controlled trial.docx by Nimran Kaur (11008865)

    Published 2024
    “…In the post-intervention assessment, 161 and 166 families continued while, at the follow-up assessment, 154 and 147 were in the intervention and control arm, respectively. The mean difference in ST on a typical day [27.7 min, 95% Confidence Interval (CI) 5.1, 50.3] at the post-intervention assessment significantly (p < 0.05) decreased in the intervention (102.6 ± 98.5 min) arm as compared with the control (130.3 ± 112.8 min) arm. …”
  11. 9091

    Mkrn1 interacts strongly with the poly(A) binding protein. by Annabelle Dold (7532576)

    Published 2020
    “…<p>(A) Western blot analysis of co-IP experiments between Venus-Mkrn1 and pAbp. α-Tubulin (lanes 1, 2) and ovaries lacking the Venus-Mkrn1 transgene (lane 4) were used as negative controls. …”
  12. 9092
  13. 9093

    Serial epithelial changes at the cartilaginous end of the rat ET after ETBD. by Yehree Kim (12635646)

    Published 2022
    “…<p>A low- and high-power field of view are shown in the left and right columns, respectively. …”
  14. 9094

    List of bacterial strains and plasmids used. by Riko Shirakawa (13040376)

    Published 2023
    “…We found that knockout mutant of RpmJ (L36), a 50S ribosomal protein, exhibited zinc resistance. …”
  15. 9095

    <i>E</i>. <i>coli</i> gene knockout mutans resistant to zinc. by Riko Shirakawa (13040376)

    Published 2023
    “…We found that knockout mutant of RpmJ (L36), a 50S ribosomal protein, exhibited zinc resistance. …”
  16. 9096

    Primers used in this study. by Riko Shirakawa (13040376)

    Published 2023
    “…We found that knockout mutant of RpmJ (L36), a 50S ribosomal protein, exhibited zinc resistance. …”
  17. 9097

    Details of intervention by groups. by Payal Seth (20797011)

    Published 2025
    “…In cluster B, ownership of individual household toilets improved by 78 percentage points (from 6% to 84%), but OD decreased by only 45 percentage points (from 95% to 50%) for the respondents. …”
  18. 9098

    Treatment impacts on hygiene behavior. by Payal Seth (20797011)

    Published 2025
    “…In cluster B, ownership of individual household toilets improved by 78 percentage points (from 6% to 84%), but OD decreased by only 45 percentage points (from 95% to 50%) for the respondents. …”
  19. 9099

    Sequence preprocessing information. by Ilze Elbere (3584057)

    Published 2020
    “…Patients were defined as Responders if their HbA1c levels during three months of metformin therapy had decreased by ≥12.6 mmol/mol (1%), while in Non-responders HbA1c were decreased by <12.6 mmol/mol (1%).…”
  20. 9100

    Characteristics of the analyzed cohorts. by Ilze Elbere (3584057)

    Published 2020
    “…Patients were defined as Responders if their HbA1c levels during three months of metformin therapy had decreased by ≥12.6 mmol/mol (1%), while in Non-responders HbA1c were decreased by <12.6 mmol/mol (1%).…”